64.77 USD
+1.49
2.35%
At close Jul 11, 4:00 PM EDT
After hours
62.95
-1.82
2.81%
1 day
2.35%
5 days
2.42%
1 month
2.14%
3 months
-2.03%
6 months
11.67%
Year to date
11.75%
1 year
22.25%
5 years
85.64%
10 years
-12.19%
 

About: Ventas owns a diversified healthcare portfolio of almost 1,400 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes almost 100 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 1% of net operating income.

Employees: 498

0
Funds holding %
of 7,312 funds
0
Analysts bullish %
of 3 analysts

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

92% more first-time investments, than exits

New positions opened: 125 | Existing positions closed: 65

39% more repeat investments, than reductions

Existing positions increased: 325 | Existing positions reduced: 233

36% more funds holding in top 10

Funds holding in top 10: 11 [Q4 2024] → 15 (+4) [Q1 2025]

18% more capital invested

Capital invested by funds: $25.2B [Q4 2024] → $29.7B (+$4.42B) [Q1 2025]

6% more funds holding

Funds holding: 745 [Q4 2024] → 789 (+44) [Q1 2025]

10% more call options, than puts

Call options by funds: $53.5M | Put options by funds: $48.8M

0.73% more ownership

Funds ownership: 97.78% [Q4 2024] → 98.5% (+0.73%) [Q1 2025]

Research analyst outlook

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$72
11%
upside
Avg. target
$73
13%
upside
High target
$75
16%
upside

3 analyst ratings

positive
67%
neutral
33%
negative
0%
Scotiabank
Nicholas Yulico
11%upside
$72
Sector Perform
Maintained
23 Jun 2025
JP Morgan
Michael Mueller
11%upside
$72
Overweight
Upgraded
23 Jun 2025
RBC Capital
Michael Carroll
16%upside
$75
Outperform
Maintained
7 May 2025

Financial journalist opinion

Based on 7 articles about VTR published over the past 30 days

Positive
Zacks Investment Research
3 days ago
Here's Why Ventas (VTR) is a Strong Momentum Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Here's Why Ventas (VTR) is a Strong Momentum Stock
Positive
Kiplinger
3 days ago
The Best Growth Stocks to Buy
Growth stocks can create significant returns for investors, but what are they and how do you find the best ones? We take a closer look here.
The Best Growth Stocks to Buy
Neutral
Business Wire
4 days ago
Ventas Announces Second Quarter 2025 Earnings Release Date and Conference Call
CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) will issue its second quarter 2025 earnings release after the close of trading on the New York Stock Exchange on Wednesday, July 30, 2025. A conference call to discuss those earnings will be held on Thursday, July 31, 2025 at 10:00 a.m. Eastern Time (9:00 a.m. Central Time). The dial-in number for the conference call is (888) 330-3576 (or +1 (646) 960-0672 for international callers), and the participant passcode is 7655497. A live webcast can b.
Ventas Announces Second Quarter 2025 Earnings Release Date and Conference Call
Positive
Zacks Investment Research
1 week ago
Ventas (VTR) Could Be a Great Choice
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Ventas (VTR) have what it takes?
Ventas (VTR) Could Be a Great Choice
Neutral
Benzinga
2 weeks ago
JPMorgan's REIT Reshuffle: Ventas Stock Climbs, Cold Storage Giants Slip
JPMorgan analyst Michael W. Mueller announced several ratings changes during the firm's quarterly CRE update webinar.
JPMorgan's REIT Reshuffle: Ventas Stock Climbs, Cold Storage Giants Slip
Positive
Seeking Alpha
2 weeks ago
Ventas: Guidance Increased As Occupancy Continues To Improve
Ventas is a healthcare REIT focused on senior housing, outpatient medical & research, and triple net properties. The company increased its FFO guidance as senior housing continues to benefit from higher occupancy and improved margins. Indeed, I estimate that Ventas may see a NOI boost as high as $190 million should robust senior housing performance continue.
Ventas: Guidance Increased As Occupancy Continues To Improve
Positive
Zacks Investment Research
4 weeks ago
Are You Looking for a High-Growth Dividend Stock?
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Ventas (VTR) have what it takes?
Are You Looking for a High-Growth Dividend Stock?
Neutral
CNBC Television
1 month ago
Final Trades: Amazon, Jefferies Financial, E.L.F. Beauty and Ventas
The Investment Committee drops their top end-of-week stock picks — what they're watching now, and why it matters.
Final Trades: Amazon, Jefferies Financial, E.L.F. Beauty and Ventas
Neutral
Seeking Alpha
1 month ago
Ventas, Inc. (VTR) CEO Debra A. Cafaro Hosts Nareit REITweek: 2025 Investor Conference (Transcript)
Ventas, Inc. (NYSE:VTR ) Bank of America Global Technology Conference June 3, 2025 1:45 PM ET Company Participants Debra A. Cafaro - Chairman & CEO J.
Ventas, Inc. (VTR) CEO Debra A. Cafaro Hosts Nareit REITweek: 2025 Investor Conference (Transcript)
Negative
Zacks Investment Research
1 month ago
Why Is Ventas (VTR) Down 2.1% Since Last Earnings Report?
Ventas (VTR) reported earnings 30 days ago. What's next for the stock?
Why Is Ventas (VTR) Down 2.1% Since Last Earnings Report?
Charts implemented using Lightweight Charts™